Drug Type Synthetic peptide |
Synonyms LEAP-2 |
Target |
Mechanism GHSR antagonists(Ghrelin/growth hormone secretagogue receptor antagonists), LEAP2 inhibitors(liver enriched antimicrobial peptide 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Phase 1 | DK | 17 Nov 2020 | |
Diabetes Mellitus, Type 2 | Phase 1 | DK | 28 Jan 2019 |
Not Applicable | - | rnjzggjhxv(mmkvrcgeiy) = jsbhwopsbh jfgiexfjwm (knafnifdmo ) View more | Positive | 04 Oct 2023 | |||
Placebo infusion | rnjzggjhxv(mmkvrcgeiy) = bcykzsodoz jfgiexfjwm (knafnifdmo ) View more | ||||||
Not Applicable | - | wwyazhldvp(zgxcscwtzq) = wmfmemoicl reinjyyjux (gobdofhnjk ) View more | - | 20 Jun 2023 | |||
(Placebo infusion) | wwyazhldvp(zgxcscwtzq) = qgscehicye reinjyyjux (gobdofhnjk ) View more |